(S (NP (NN Control) (NN theory)) (VP (VBZ has) (VP (VBN seen) (NP (ADJP (RB recently) (JJ impactful)) (NNS applications)) (PP (PP (IN in) (NP (NN network) (NN science))) (, ,) (RB especially) (PP (IN in) (NP (NP (NNS connections)) (PP (IN with) (NP (NP (NNS applications)) (PP (IN in) (NP (NN network) (NN medicine)))))))))) (. .))
(S (NP (NP (DT A) (JJ key) (NN topic)) (PP (IN of) (NP (NN research)))) (VP (VBZ is) (SBAR (IN that) (S (NP (NP (PP (IN of) (S (VP (VBG finding) (NP (NP (JJ minimal) (JJ external) (NNS interventions)) (SBAR (WHNP (WDT that)) (S (VP (VBP offer) (NP (NP (NN control)) (PP (IN over) (NP (DT the) (NNS dynamics))))))))))) (PP (IN of) (NP (DT a) (VBN given) (NN network)))) (, ,) (NP (DT a) (NN problem))) (VP (VBN known) (PP (IN as) (NP (NN network) (NN controllability))))))) (. .))
(S (NP (PRP We)) (VP (VBP propose) (PP (IN in) (NP (DT this) (NN article))) (NP (NP (DT a) (JJ new) (NN solution)) (PP (IN for) (NP (NP (DT this) (NN problem)) (PP (VBN based) (PP (IN on) (NP (JJ genetic) (NNS algorithms)))))))) (. .))
(S (NP (PRP We)) (VP (VBP tailor) (NP (PRP$ our) (NN solution)) (PP (IN for) (NP (NP (NP (NNS applications)) (PP (IN in) (NP (JJ computational) (NN drug) (NN repurposing)))) (, ,) (VP (VBG seeking) (S (VP (TO to) (VP (VB maximise) (NP (NP (PRP$ its) (NN use)) (PP (IN of) (NP (ADJP (NNP FDA) (HYPH -) (VBN approved)) (NN drug) (NNS targets)))) (PP (IN in) (NP (DT a) (VBN given) (NML (ADJP (NN disease) (HYPH -) (JJ specific)) (NML (NN protein) (HYPH -) (NN protein)) (NN interaction)) (NN network)))))))))) (. .))
(S (NP (PRP We)) (VP (VBP show) (SBAR (WHADVP (WRB how)) (S (NP (PRP$ our) (NN algorithm)) (VP (VBZ identifies) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (ADJP (RB potentially) (JJ efficient)) (NNS drugs)))) (PP (IN for) (NP (NP (NN breast)) (, ,) (NP (JJ ovarian)) (, ,) (CC and) (NP (JJ pancreatic) (NN cancer)))))))) (. .))
(S (ADVP (RB Overall)) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (PRP$ our) (JJ new) (NN algorithm)) (VP (VBZ is) (ADJP (RBR more) (JJ efficient) (PP (IN in) (S (VP (VBG identifying) (NP (JJ relevant) (NN drug) (NNS targets)) (PP (IN in) (NP (DT a) (NN disease) (NN network))) (, ,) (S (VP (VBG advancing) (NP (NP (DT the) (JJ computational) (NNS solutions)) (VP (VBN needed) (PP (IN for) (NP (NML (NML (JJ new) (JJ therapeutic)) (CC and) (NML (NN drug))) (VBG repurposing) (NNS approaches))))))))))))))) (. .))
